scholarly journals Plasma cell leukemia with different expression of CD56 marker in the peripheral blood and bone marrow: A case report

2020 ◽  
Vol 8 (2) ◽  
pp. 23-24
Author(s):  
Akram Deghady ◽  
Nahla Farahat ◽  
Abeer Elhadidy ◽  
Hanaa Donia ◽  
Hadeer Rashid
2021 ◽  
pp. 21-22
Author(s):  
Gaurav Sharma ◽  
Smita Sharma

Introduction: Primary Plasma Cell Leukemia (pPCL) is Plasma cell dyscrasia subtype which is rare and aggressive. It carries very poor prognosis. It has unique clinical and laboratory prole. Its rst clinical presentation is leukemia. Peripheral blood examination shows circulating mature looking yet clonal, plasma cells. On molecular and cytogenetic examinations, many aberrations are seen which are unique and make it a distinct entity different from traditional Multiple Myeloma (MM). Case presentation: 37 yr old Indian female presented with difculty in breathing for last 3 months and was initially evaluated for cardiac function & COVID-19 screening. Peripheral blood examination revealed circulating plasma cells. Bone marrow apirate conrmed the initial diagnosis of pPCL. She received BIODRONATE + Inj. BORTEZOMIB + Inj. CYCLOPHOSPHAMIDE + Tab Dexa and was advised for PETscan and skeletal survey. But due to nancial constraints, family decided to go for complete systemic workup in next phase of chemotherapy cycle. She was discharged with advise to be in close follow up and to complete her treatment cycles. Discussion: pPCL needs to be diagnosed promptly to formulate optimal intensive therapy. This atypical presentation with shortness of breath of rare entity of pPCLin such young age emphasizes the need for quick and thorough initial workup. Conclusion: Because of rarity of this disease, there is paucity of literature from India and especially the impact of the standard therapies in resource poor countries. Our case report highlights these challenges for conclusive management of this rare entity


1971 ◽  
Vol 45 (1) ◽  
pp. 36-49 ◽  
Author(s):  
G. Jean ◽  
G. Labertenghi-Deliliers ◽  
T. Ranzi ◽  
E. Polli

2019 ◽  
Vol 10 (3) ◽  
pp. 161-165
Author(s):  
Akriti G Jain ◽  
Mohammed Faisal-Uddin ◽  
Abdul K Khan ◽  
Mohammed Wazir ◽  
Qi Shen ◽  
...  

1983 ◽  
Vol 69 (6) ◽  
pp. 589-591 ◽  
Author(s):  
Leonardo Pacilli ◽  
Paolo Ferraro ◽  
Silvia Cochi ◽  
Antonio De Laurenzi

Three patients with plasma cell leukemia are reported. Two of them had a previous history of myeloma; the third one started with a plasma cell leukemia. Diagnosis was made from the required presence of 20% plasma cells in the peripheral blood. In all 3 cases, bone marrow aspiration and peripheral blood showed plasma cells strongly positive for acid phosphatase and alpha-naphthyl acetate esterase, and negative for periodic acid-Schiff. The first patient was treated with a polychemotherapy regimen that included vincristine, cyclophosphamide, chlorambucil and prednisone, and the second patient with melphalan and prednisone; the third one, who started with plasma cell leukemia, received total body irradiation at the dose of 600 rad. The results of the therapy and survival time, which was never more than 3 months, are in accord with other reports in the literature.


Sign in / Sign up

Export Citation Format

Share Document